75岁以上患者骨质疏松治疗的骨折复位:一项系统评价和荟萃分析。

Fractures reduction with osteoporotic treatments in patients over 75-year-old: A systematic review and meta-analysis.

作者信息

Guillaumin Michel, Poirson Bastien, Gerazime Aurélie, Puyraveau Marc, Tannou Thomas, Mauny Fréderic, Toussirot Éric

机构信息

Département de Gériatrie, CHU, Besançon, France.

Unité de Méthodologie, INSERM CIC-1431 Centre Investigation Clinique CHU, Besançon, France.

出版信息

Front Aging. 2022 Nov 2;3:845886. doi: 10.3389/fragi.2022.845886. eCollection 2022.

Abstract

Osteoporosis consists in the reduction of bone mineral density and increased risk of fracture. Age is a risk factor for osteoporosis. Although many treatments are available for osteoporosis, there is limited data regarding their efficacy in older people. To evaluate the efficacy of osteoporosis treatments in patients over 75 years old. We reviewed all published studies in MEDLINE, Cochrane and EMBASE including patients over 75 years old, treated by osteoporosis drugs, and focused on vertebral fractures or hip fractures. We identified 4,393 records for review; 4,216 were excluded after title/abstract review. After full text review, 19 records were included in the systematic review. Most studies showed a reduction in vertebral fracture with osteoporosis treatments, but non-significant results were observed for hip fractures. Meta-analysis of 10 studies showed that lack of treatment was significantly associated with an increased risk of vertebral fractures at one (OR = 3.67; 95%CI = 2.50-5.38) and 3 years (OR = 2.19; 95%CI = 1.44-3.34), and for hip fractures at one (OR = 2.14; 95%CI = 1.09-4.22) and 3 years (OR = 1.31, 95%CI = 1.12-1.53). A reduction in the risk of vertebral fractures with osteoporosis treatments was observed in most of the studies included and meta-analysis showed that lack of treatment was significantly associated with an increased risk of vertebral fractures. Concerning hip fractures, majority of included studies did not show a significant reduction in the occurrence of hip fractures with osteoporotic treatments, but meta-analysis showed an increased risk of hip fractures without osteoporotic treatment. However, most of the data derived from and preplanned analyses or observational studies.

摘要

骨质疏松症表现为骨矿物质密度降低以及骨折风险增加。年龄是骨质疏松症的一个风险因素。尽管有多种治疗骨质疏松症的方法,但关于这些方法在老年人中的疗效数据有限。为了评估骨质疏松症治疗方法对75岁以上患者的疗效,我们检索了MEDLINE、Cochrane和EMBASE中所有已发表的研究,这些研究纳入了75岁以上接受骨质疏松症药物治疗的患者,并重点关注椎体骨折或髋部骨折。我们识别出4393条记录以供审查;经标题/摘要审查后,排除了4216条记录。经过全文审查,19条记录被纳入系统评价。大多数研究表明,骨质疏松症治疗可降低椎体骨折发生率,但髋部骨折方面未观察到显著效果。对10项研究的荟萃分析表明,未接受治疗与1年(OR = 3.67;95%CI = 2.50 - 5.38)和3年(OR = 2.19;95%CI = 1.44 - 3.34)时椎体骨折风险增加显著相关,对于髋部骨折,1年(OR = 2.14;95%CI = 1.09 - 4.22)和3年(OR = 1.31,95%CI = 1.12 - 1.53)时也是如此。在纳入的大多数研究中都观察到骨质疏松症治疗可降低椎体骨折风险,荟萃分析表明未接受治疗与椎体骨折风险增加显著相关。关于髋部骨折,大多数纳入研究未显示骨质疏松症治疗能显著降低髋部骨折发生率,但荟萃分析表明未进行骨质疏松症治疗会增加髋部骨折风险。然而,大多数数据来自预先计划的分析或观察性研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07a1/9667050/01034f41e760/fragi-03-845886-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索